Transformation of dolutegravir into an ultra-long-acting parenteral prodrug formulation.
Nat Commun
; 13(1): 3226, 2022 06 09.
Article
in En
| MEDLINE
| ID: mdl-35680875
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Prodrugs
/
HIV Infections
/
HIV Integrase Inhibitors
Limits:
Humans
Language:
En
Journal:
Nat Commun
Journal subject:
BIOLOGIA
/
CIENCIA
Year:
2022
Document type:
Article
Affiliation country:
United States
Country of publication:
United kingdom